Michael Cunniffe is Lead of Finance at ATAI Life Sciences. Prior to joining ATAI, Michael worked in senior finance roles for early stage gene-therapy and listed vaccines companies. These roles covered corporate strategy, forecasting and planning, controlling, operating models and fund raising focused on the US and European healthcare markets.
During his time at Ernst & Young he advised pre-commercial life science companies on processes, controls and enterprise systems. He also brings broad international experience from continuous corporate finance roles with a Fortune 500 while based in their West Africa, Europe, the Middle East and Australian operations. Michael has a Masters in Finance from London Business School.